The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) (14,15) is a screening instrument designed for detecting a variety of cognitive impairments associated with schizophrenic illness. The RBANS provides both a total cognitive impairment score and explicit cognitive functioning index scores—measures of language, visual functions, memory, and attention. The screen was standardized on a U.S. Census-matched adult population and is sensitive in the detection of deficits commonly associated with acute schizophrenic illness (14). The instrument is relatively brief to administer (25 to 30 minutes) and has demonstrated excellent test-retest reliability and convergent validity (14,15). For example, it has been found to correlate highly with established neuropsychologic tests that examine deficits commonly associated with schizophrenia, including memory and attention dysfunction (15). The screen was not found to correlate with symptoms but was found to correlate with employment outcome (15). Overall, the RBANS has been shown to have great utility as a cognitive screen for detecting cognitive deficits among patients with schizophrenia and appears to be highly appropriate for use in the psychiatric emergency service.